Atovaquone

CAS No. 95233-18-4

Atovaquone( BW 566C | BW 556C-80 )

Catalog No. M16808 CAS No. 95233-18-4

Atovaquone is a medication used to treat or prevent for pneumocystis pneumonia, toxoplasmosis, malaria, and babesia.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 46 In Stock
10MG 41 In Stock
25MG 77 In Stock
50MG 137 In Stock
100MG 184 In Stock
200MG 276 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Atovaquone
  • Note
    Research use only, not for human use.
  • Brief Description
    Atovaquone is a medication used to treat or prevent for pneumocystis pneumonia, toxoplasmosis, malaria, and babesia.
  • Description
    Atovaquone is a medication used to treat or prevent for pneumocystis pneumonia, toxoplasmosis, malaria, and babesia.
  • In Vitro
    ——
  • In Vivo
    Animal Model:ICSBP?/??mice infected with 10 cysts of the ME49 strain of?T. gondii Dosage:100 mg/kg Administration:Oral administration Result:Improved mice survival rate to 22 days compared to vehicle.
  • Synonyms
    BW 566C | BW 556C-80
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Dehydrogenase
  • Recptor
    DHODH| Cytochrome b
  • Research Area
    Infection
  • Indication
    ——

Chemical Information

  • CAS Number
    95233-18-4
  • Formula Weight
    366.84
  • Molecular Formula
    C22H19ClO3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 5 mg/mL (13.62 mM)
  • SMILES
    O=C1C([C@H]2CC[C@H](C3=CC=C(Cl)C=C3)CC2)=C(O)C(C4=C1C=CC=C4)=O
  • Chemical Name
    trans-2-[4-(4-chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthalenedione

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Winter RW, et al. Exp Parasitol. 2008 Apr; 118(4):487-97.
molnova catalog
related products
  • SW209049

    SW209049 is a stearoyl-CoA 9-desaturase inhibitor. SW209049 exhivits potent activity against H2122 cell with IC50 of 0.13uM.

  • Enoxolone

    Enoximone is a selective phosphodiesterase inhibitor with vasodilating and positive inotropic activity that does not cause changes in myocardial oxygen consumption.

  • DHODH-IN-16

    DHODH-IN-16 is an effective inhibitor of dihydroorotate dehydrogenase (DHODH, IC50 = 0.396 nM for human).